• Fatigue or low energy: Persistent tiredness, reduced stamina or feeling easily depleted.
• Respiratory symptoms: Nasal congestion, coughing, wheezing or shortness of breath.
• Allergy-type reactions: Sneezing, watery eyes, sinus irritation or seasonal-type symptoms.
• Headaches or neurological discomfort: Head pressure, headaches, dizziness or difficulty concentrating.
• Digestive changes: Nausea, bloating, vomiting or irregular bowel habits.
• Skin concerns: Rashes, itching, irritation or recurrent dermatitis.
• Mood or cognitive changes: Irritability, low mood, restlessness or problems with focus or clarity.
• Sleep disruption: Difficulty falling asleep or staying asleep.
• Balance or coordination issues: Feeling unsteady, episodes of vertigo or blurred vision.
• Unexplained pain or sensitivity: Generalised aches, muscle discomfort or increased sensitivity.
• Recurrent infections or immune symptoms: Frequent colds, sore throats or lowered resilience. Note: What about suspected mold exposure at home?

The MycoTOX Profile provides a comprehensive assessment of mycotoxin exposure by screening for 11 different mycotoxins produced by over 40 species of mould. Using advanced mass spectrometry (MS/MS), the test measures a wide range of fungal toxins including ochratoxin A, aflatoxin M1, sterigmatocystin, zearalenone, gliotoxin, roridin E, verrucarin A, enniatin B1, mycophenolic acid, dihydrocitrinone and chaetoglobosin A. This broad coverage offers a detailed overview of mould-related toxic load from a single urine sample.

The test may be clinically useful when investigating symptoms that could be associated with environmental or food-based mould exposure. By assessing metabolites linked with major mould genera such as Aspergillus, Penicillium, Fusarium and Stachybotrys, the profile can help identify patterns of exposure relevant to fatigue, respiratory irritation, skin reactions, neurological symptoms or digestive disturbance. The molecular specificity of MS/MS detection also allows for evaluation of low-level exposures.

The MycoTOX Profile offers a structured way to assess mycotoxin burden and can be used to support clinical interpretation when evaluating unexplained symptom patterns. Its broad toxin panel provides practitioners with detailed biochemical information to help inform next steps, guide environmental assessment or complement broader metabolic or detoxification testing strategies.

Specimen requirements:

Urine: 10 mL of the first morning urine before food or drink is suggested.  Fasting for 12 hours may increase the excretion of mycotoxins from the adipose tissue.  However, fasting is not recommended if running this test in combination with other urine tests.

Patients who need to urinate during the night should collect the sample that has been in the body the longest. If the time frame between going to bed and urinating at 2:30 AM is at least about 4-5 hours, the sample could be taken from the night urination. Do not mix together a middle of the night sample and morning sample.